These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 22926603

  • 1. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
    Nielsen J, Nielsen RE, Correll CU.
    J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [Abstract] [Full Text] [Related]

  • 3. Geographical and temporal variations in clozapine prescription for schizophrenia.
    Nielsen J, Røge R, Schjerning O, Sørensen HJ, Taylor D.
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K, Morriss R.
    Psychopharmacol Bull; 2010 Nov; 43(2):67-81. PubMed ID: 21052043
    [Abstract] [Full Text] [Related]

  • 5. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
    Stroup TS, Gerhard T, Crystal S, Huang C, Olfson M.
    Am J Psychiatry; 2016 Feb 01; 173(2):166-73. PubMed ID: 26541815
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic prescription filling in patients with schizophrenia or schizoaffective disorder.
    Reutfors J, Brandt L, Stephansson O, Kieler H, Andersen M, Bodén R.
    J Clin Psychopharmacol; 2013 Dec 01; 33(6):759-65. PubMed ID: 24126686
    [Abstract] [Full Text] [Related]

  • 7. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
    Nielsen J, Kane JM, Correll CU.
    Bipolar Disord; 2012 Dec 01; 14(8):863-9. PubMed ID: 23107278
    [Abstract] [Full Text] [Related]

  • 8. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026
    [Abstract] [Full Text] [Related]

  • 9. Increased use of antibiotics in patients treated with clozapine.
    Nielsen J, Foldager L, Meyer JM.
    Eur Neuropsychopharmacol; 2009 Jul 15; 19(7):483-6. PubMed ID: 19356909
    [Abstract] [Full Text] [Related]

  • 10. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ.
    Ann Pharmacother; 2008 Jun 15; 42(6):852-60. PubMed ID: 18477732
    [Abstract] [Full Text] [Related]

  • 11. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
    Ward A, Ishak K, Proskorovsky I, Caro J.
    Clin Ther; 2006 Nov 15; 28(11):1912-21. PubMed ID: 17213012
    [Abstract] [Full Text] [Related]

  • 12. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
    Broder MS, Bates JA, Jing Y, Hebden T, Forbes RA, Chang E.
    J Med Econ; 2012 Nov 15; 15(1):105-11. PubMed ID: 21991926
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictors of clozapine discontinuation in patients with schizophrenia.
    Krivoy A, Malka L, Fischel T, Weizman A, Valevski A.
    Int Clin Psychopharmacol; 2011 Nov 15; 26(6):311-5. PubMed ID: 21849905
    [Abstract] [Full Text] [Related]

  • 15. Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary.
    Bitter I, Katona L, Zámbori J, Takács P, Fehér L, Diels J, Bacskai M, Lang Z, Gyáni G, Czobor P.
    Eur Neuropsychopharmacol; 2013 Nov 15; 23(11):1383-90. PubMed ID: 23477752
    [Abstract] [Full Text] [Related]

  • 16. Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study.
    Rohde C, Polcwiartek C, Correll CU, Nielsen J.
    J Pers Disord; 2018 Dec 15; 32(6):823-837. PubMed ID: 29120277
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Kim.
    J Psychopharmacol; 2010 Jul 15; 24(7):981-6. PubMed ID: 19942641
    [Abstract] [Full Text] [Related]

  • 19. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
    Kennedy J, Tien YY, Cohen LJ, Sclar DA, Liu D, Blodgett EG, Engle J.
    Clin Ther; 2009 Dec 15; 31(12):2931-9. PubMed ID: 20110033
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.